Literature DB >> 16678245

Effects of the H3-receptor inverse agonist thioperamide on the psychomotor effects induced by acutely and repeatedly given cocaine in C57BL/6J mice.

Christian Brabant1, Etienne Quertemont, Ezio Tirelli.   

Abstract

Previous studies have shown that histamine H(3) blockers potentiate the psychomotor and rewarding effects of cocaine. The present study examined the influence of thioperamide, an inverse H(3) receptor agonist, on the development of psychomotor sensitization and stereotyped activity induced by acute or intermittent cocaine in C57BL/6J mice. In the first experiment, mice were injected i.p. with saline, 10 or 20 mg/kg thioperamide and saline or 8 mg/kg cocaine, 10 min apart, before being tested for their locomotor activity (providing data on the acute effects of thioperamide on cocaine-induced activity). Subsequently, mice were treated in the same manner every other day over six additional sessions. Sensitization was assessed by the responsiveness to a cocaine challenge (8 mg/kg, i.p.) given 2 and 14 days following the intermittent treatment. In experiments 2 and 3, we tested the effects of thioperamide (10 or 20 mg/kg, i.p.) on gnawing and sniffing induced or affected by relatively high doses of cocaine (24 or 32 mg/kg, s.c.), the drugs being given 10 min apart. In the first experiment, both doses of thioperamide amplified cocaine-induced psychomotor hyperactivity almost on all experimental sessions. However, the histamine inverse agonist did not affect the induction of a psychomotor sensitization. All cocaine-treated mice showed similar levels of sensitized activity 2 and 14 days after the intermittent treatments, whether they received thioperamide or not. The second and the third experiments showed that thioperamide did not affect gnawing and sniffing induced by cocaine. Taken together, these results indicate that H(3) receptors clearly contribute to the neurobiological mechanisms of the locomotor component of cocaine-induced psychomotor activation, but less likely to those underlying the development of cocaine behavioral sensitization or the expression of cocaine-induced oro-facial stereotypies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678245     DOI: 10.1016/j.pbb.2006.03.018

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward.

Authors:  Christian Brabant; Etienne Quertemont; Christelle Anaclet; Jian-Sheng Lin; Hiroshi Ohtsu; Ezio Tirelli
Journal:  Psychopharmacology (Berl)       Date:  2006-10-28       Impact factor: 4.530

2.  Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function.

Authors:  Carla Ferrada; Sergi Ferré; Vicent Casadó; Antonio Cortés; Zuzana Justinova; Chanel Barnes; Enric I Canela; Steven R Goldberg; Rob Leurs; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

3.  Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice.

Authors:  Saara Nuutinen; Minnamaija Lintunen; Jenni Vanhanen; Tiia Ojala; Stanislav Rozov; Pertti Panula
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

Review 4.  Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders.

Authors:  Patricia Di Ciano; Christian S Hendershot; Bernard Le Foll
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.

Authors:  Matthew L Banks; Daniel F Manvich; Rayna M Bauzo; Leonard L Howell
Journal:  Pharmacology       Date:  2009-01-15       Impact factor: 2.547

6.  Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.

Authors:  Christian Brabant; Livia Alleva; Thierry Grisar; Etienne Quertemont; Bernard Lakaye; Hiroshi Ohtsu; Jian-Sheng Lin; Peter Jatlow; Marina R Picciotto; Ezio Tirelli
Journal:  Psychopharmacology (Berl)       Date:  2008-10-09       Impact factor: 4.530

Review 7.  Histamine H₃ receptors, the complex interaction with dopamine and its implications for addiction.

Authors:  B A Ellenbroek
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

8.  Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.

Authors:  Jenni Vanhanen; Marja Kinnunen; Saara Nuutinen; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2014-10-12       Impact factor: 4.530

Review 9.  The histaminergic network in the brain: basic organization and role in disease.

Authors:  Pertti Panula; Saara Nuutinen
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

10.  Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats.

Authors:  A Belin-Rauscent; J Lacoste; O Hermine; A Moussy; B J Everitt; David Belin
Journal:  Psychopharmacology (Berl)       Date:  2018-03-08       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.